Bayer share price logo

Bayer

OTC: BAYRY

Large Cap

$12.47

+0.05

(+0.40%)

as on

Bayer Stock Performance

as on October 17, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $12.39
    $12.52
    downward going graph

    0.64%

    Downside

    0.40%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Bayer share price movements today

Previous Close
$12.42
Open
$12.51
Volume
1.0M
Market Cap
$49.7B
Dividend Yield
0.26%
Day's Low - High
$12.39 - $12.52

Bayer Historical Returns

1 Month Return
-11.75 %
3 Month Return
-9.64 %
1 Year Return
+ 59.46 %
3 Year Return
+ 9.29 %
5 Year Return
0 %

Bayer Stock Fundamentals & Key Indicators

Check Bayer market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$49.7B

EPS (TTM)

-0.425

Dividend Yield

0.26%

PE Ratio (TTM)

-25.23

Industry PE ratio

9.58

PEG Ratio

0.00

Return On Equity TTM

-6.10%

Bayer vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bayer with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$49.7BNA-25.2359.05%0.26%
StrongBuy$1.1T428.43%41.8783.40%0.53%
StrongBuy$500.9B161.06%79.8471.48%2.44%
Buy$611.9B58.44%38.4068.81%2.08%
Buy$363.6B86.33%115.3675.38%2.34%

Stock Returns calculator for Bayer Stock including INR - Dollar returns

The Bayer stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Bayer investment value today

Current value as on today

₹1,72,070

Returns

₹72,070

(+72.07%)

Returns from Bayer Stock

₹59,463 (+59.46%)

Dollar Impact

₹12,607 (+12.61%)

Indian Investors' Interest in Bayer Stock

Search interest for Bayer Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:8% versus previous 30 day period

Bayer Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
13,765
11,144
9,968
11,729
13,738
10,739
9,660
11,330
13,625
10,872
Gross Profit
8,302
6,150
4,878
6,006
8,113
6,375
5,353
6,871
8,307
6,332
Operating Income
3,248
930
-406
3,532
2,324
13
-543
1,686
3,163
891
EBITDA
4,366
1,727
1,056
1,671
3,588
236
606
2,016
4,437
2,157
Interest Expense
648
682
642
385
584
561
890
668
690
622
Depreciation
1,113
1,142
4,761
1,767
1,174
272
1,005
330
1,274
1,158
Income Before Tax
2,591
-97
-4,347
-481
1,830
-426
-1,161
-3,340
3,038
321
Income Tax Expense
589
-71
-153
-153
526
-236
-201
374
225
92
Net Income
2,000
-34
-4,183
-335
1,299
-199
-960
-3,721
2,808
219
Net Profit Margin
60.31%
55.19%
48.94%
51.21%
59.06%
59.36%
55.41%
60.65%
60.97%
58.24%

Bayer Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
35,015
39,586
43,545
41,400
44,081
50,739
47,637
46,606
43,776
Gross Profit
23,633
22,576
26,078
22,262
27,265
30,868
27,888
25,336
25,918
Operating Income
5,903
3,914
5,041
-2,939
6,975
6,264
-150
3,327
6,679
EBITDA
7,735
6,304
8,736
-2,504
6,953
10,493
4,324
8,807
10,566
Interest Expense
871
1,615
1,828
1,585
1,347
1,857
2,047
2,358
1,654
Depreciation
2,117
2,938
4,409
13,259
3,725
3,966
3,898
8,783
3,887
Income Before Tax
4,577
2,318
2,880
-17,250
2,046
4,670
-1,621
-2,334
-3,005
Income Tax Expense
1,329
607
450
-1,689
1,024
504
1,321
212
447
Net Income
7,336
1,695
2,430
-15,561
1,000
4,150
-2,941
-2,552
-3,477
Net Profit Margin
67.49%
57.03%
59.89%
53.77%
61.85%
60.84%
58.54%
54.36%
59.21%

Bayer Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
2,000
-34
-4,194
-328
1,304
-190
-959
-3,721
2,808
222
Operating Cash Flow
-2,180
1,901
2,111
4,997
-1,015
1,058
1,591
3,561
-1,940
296
Investing Cash Flow
143
-2,603
3,758
-1,294
161
154
-1,314
-582
196
-792
Financing Cash Flow
867
-692
-5,054
-2,109
-1,241
-482
1,187
-2,214
742
-1,030
Change in Cash
-1,182
-837
731
1,572
-2,176
542
1,579
770
-1,072
-1,482

Bayer Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
3,248
1,711
2,430
-15,561
1,022
4,166
-2,941
-2,546
-3,477
Operating Cash Flow
8,134
7,917
8,207
4,903
5,089
7,093
5,117
7,368
4,390
Investing Cash Flow
-432
-34,152
-671
-4,073
855
-2,381
-4,014
164
-1,545
Financing Cash Flow
-1,881
23,432
-8,389
423
-5,645
-4,220
-679
-7,178
-2,099
Change in Cash
5,682
-3,383
-867
1,006
373
607
736
284
1,211

Global Institutional Holdings in Bayer

Check out the Institutions with significant holdings in Bayer.

Funds
Holdings
Irving Kahn
0.17%
Dodge & Cox Funds
0.16%
CresAlta
0.00%
ADVISORS' INNER CIRCLE FUND
0.00%
ActivePassive
0.00%

Bayer News & Key Events

  • img

    Today's Timeline - 08 October

    Thu, 12:00 PM

    -

    Bayer's FDA accepted supplemental new drug application for Kerendia, targeting chronic kidney disease without diabetes.

    Thu, 06:15 PM

    -

    Bayer partners with Melissa Joan Hart to promote Lynkuet, a hormone-free treatment for menopause-related hot flashes.

Insights on Bayer

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, BAYRY stock has moved up by 59.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly & Co. has given 40.1% return, outperforming this stock by 30.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Merck & Co., Inc. has given 72.1% return, outperforming this stock by 12.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Bayer Aktiengesellschaft American Depositary Shares have seen a decline in revenue for the last two quarters. The revenue dropped from $13.40 billion to $10.87 billion, which represents an average decrease of 18.9% per quarter.

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Bayer Aktiengesellschaft's American Depositary Shares have experienced a significant decline in net profit over the last two quarters. The net profit dropped from $2.76 billion to $218.99 million, representing an average decrease of 92.1% per quarter.

About Bayer

Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries. Its extensive operations are strategically segmented into Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division concentrates on developing and marketing prescription medications, with key areas including cardiology and women's healthcare. It also offers specialized therapeutic solutions for oncology, hematology, and ophthalmology, alongside diagnostic imaging equipment, contrast agents, and advanced cell and gene therapies. Bayer's Consumer Health segment provides a wide array of non-prescription (over-the-counter) medicines, medical devices, medicated skincare items, and nutritional supplements. These self-care products address diverse health needs such as dermatology, dietary support, pain relief, cardiovascular risk prevention, digestive issues, allergy management, and cold and cough symptoms. The Crop Science division supports the agricultural sector with chemical and biological crop protection products, genetically enhanced plant traits, seeds, digital farming tools, and solutions for pest and weed control. This segment also manages the breeding, propagation, production, and specialized treatment of seeds, complemented by dedicated customer service for farmers. Bayer is actively involved in numerous strategic collaborations to bolster its research and development pipeline. These partnerships include an agreement with MD Anderson Cancer Center for oncology drug development, a research and licensing deal with Dewpoint Therapeutics, Inc. focused on novel treatments for cardiovascular and gynecological diseases, and collaborations with Exscientia Ltd, Foundation Medicine Inc., Evotec AG, and Arvinas Inc. Additionally, the company maintains strategic research alliances with the University of Oxford for gynecological therapies and with Kyoto University to discover potential new drugs for pulmonary conditions. The company’s products reach a broad market through various distribution channels, including wholesale partners, independent and chain pharmacies, supermarkets, online and other retail outlets, hospitals, and direct sales to agricultural producers. Bayer Aktiengesellschaft was established in 1863 and is headquartered in Leverkusen, Germany.
OrganisationBayer
HeadquartersKaiser-Wilhelm-Allee 1, Leverkusen, NW, 51368, DE
IndustryDrug Manufacturers - General
CEOBill Anderson

Key Management of Bayer

Name

Title

Mr. Michael Preuss

Head of Communications, Government Relations and Corporate Brand

Mr. Stefan Oelrich

President of the Pharmaceuticals Division & Member of the Board of Management

Ms. Heike Prinz

Chief Talent Officer, Labor Director & Member of Management Board

Mr. Julio Triana

Member of Management Board & President of Consumer Health Division

Mr. Alex Buschermohle

Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division

Mr. Bill Dodero

General Counsel and Senior VP of Law Patents & Compliance

Mr. William N. Anderson

Chairman of the Management Board & CEO

Dr. Judith Hartmann

CFO & Member of Management Board

Mr. Rodrigo Santos

Member of Management Board, Head of the Crop Science Division & President of Crop Science Division

Ms. Jana Marlen Ackermann

Head of the Investor Relations

FAQs

What is Bayer share price today?

Bayer share price today is $12.47 as on at the close of the market. Bayer share today touched a day high of $12.52 and a low of $12.39.

What is the 52 week high and 52 week low for Bayer share?

Bayer share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Bayer stock price today i.e. is closed at $12.47,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Bayer's market capitalisation today?

Bayer market capitalisation is $0.05T as on .

How to invest in Bayer Stock (BAYRY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bayer on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Bayer Stock (BAYRY) from India?

Indian investors can start investing in Bayer (BAYRY) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Bayer stock (as per the Rupee-Dollar exchange rate as on ). Based on Bayer share’s latest price of $12.47 as on October 17, 2026 at 1:29 am IST, you will get 0.8019 shares of Bayer. Learn more about fractional shares .